Version 5.4
Bos taurus Protein: LOC504389
Summary
InnateDB Protein IDBP-691119.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol LOC504389
Protein Name transcription elongation factor A N-terminal and central domain-containing protein
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000023859
InnateDB Gene IDBG-639006 (LOC504389)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 10 interaction(s) predicted by orthology.
Predicted by orthology
Total 10 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003677 DNA binding
GO:0008270 zinc ion binding
Biological Process
GO:0006351 transcription, DNA-templated
GO:0006357 regulation of transcription from RNA polymerase II promoter
GO:0032784 regulation of DNA-templated transcription, elongation
Cellular Component
GO:0005634 nucleus
Protein Structure and Domains
PDB ID
InterPro IPR003618 Transcription elongation factor S-II, central domain
IPR016492 Transcription elongation factor, TFIIS-related
IPR017890 Transcription elongation factor S-IIM
IPR017923 Transcription factor IIS, N-terminal
PFAM PF07500
PF08711
PRINTS
PIRSF PIRSF006704
SMART SM00510
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL A0JNK7
UniProt Splice Variant
Entrez Gene 504389
UniGene Bt.30852
RefSeq NP_001019643
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC126748 DAAA02074911
GenPept AAI26749

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca